๐๏ธ OncologyInjection (SC)
Elrexfio
Elranatamab
BCMA-directed bispecific T-cell engager for relapsed/refractory multiple myeloma.
Form
Injection (SC)
Uses
1
Side effects
5
Category
Oncology
01
What is Elrexfio used for?
- Relapsed/refractory multiple myeloma
02
Elranatamab side effects
The following side effects have been reported for Elranatamab. Their order does not indicate how often an effect occurs.
Cytokine release syndrome
Infections
ICANS (neurotoxicity)
Neutropenia
Anemia
03
Elranatamab warnings & precautions
- Black box: CRS and neurologic toxicity
- REMS required. Step-up dosing
- Serious infections
Loading FDA dataโฆ
04
Frequently asked questions
05
Related medications
Share
Share this drug info.
Help friends and family understand Elrexfio in plain language.
Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.